opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID ... BioNTech and Moderna are also involved in ...
MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid vaccine. The European Patent Office (EPO) has upheld the validity of one of ...
Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.
Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...
London: Moderna has won a case at the European Patent Office against Pfizer and BioNTech in a dispute over its COVID-19 vaccine, the company said on Friday. The vaccine maker has been locked in an ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and ...
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する